{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Famindr.com%2Fepisodes%2F54-csf-biomarkers-alzheimers-disease-august-2020-lrHO5_VQ","width":444,"version":"1.0","type":"rich","title":"54 - CSF Biomarkers: Alzheimer's Disease August 2020","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/9a8ef428-72db-47cb-a5cb-a6a258a13785/8d9a2929-16d7-4637-a141-a288ab557841/slide8.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/062c7869-d462-48ca-a944-7c1f467a85cb\" height=\"200\" width=\"100%\" title=\"54 - CSF Biomarkers: Alzheimer&apos;s Disease August 2020\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"In this episode, Alex covers the latest research involving CSF biomarkers as a critical diagnostic tool in Alzheimer’s Disease identification and treatment. You’ll hear about some of the more typical clinical CSF biomarkers seen in AD, as well as the signature CSF AD biomarker profile, and you’ll also learn about how some of these CSF  biomarkers relate to the different stages of AD progression and severity. "}